Search results

Filter

Filetype

Your search for "*" yielded 571244 hits

Cancerfonden grants support early-career researchers in exploring new approaches to understanding and treating cancer

For many cancer patients, successful treatment depends on whether the disease is detected early or responds to existing therapies. With new grants from the Swedish Cancer Society (Cancerfonden), three postdoctoral researchers at Lund University’s Lund Stem Cell Center will investigate new drivers of cancer development and how the immune system can be more effectively mobilised against tumors. In M

https://www.stemcellcenter.lu.se/article/cancerfonden-grants-support-early-career-researchers-exploring-new-approaches-understanding-and - 2026-09-11

UniStem Day 2026: Opening a door to a life in science

What happens when 200 high school students step inside a research center for a full day of science? Curiosity ignites, questions multiply, and for many, new futures begin to feel possible. At the end of March, Lund Stem Cell Center welcomed students from Lars Erik Larsson gymnasiet in Lund, Söderslättsgymnasiet in Trelleborg, and Malmö Borgarskola, Malmö Latinskola, and Sjölins Gymnasium in Malmö

https://www.stemcellcenter.lu.se/article/unistem-day-2026-opening-door-life-science - 2026-09-11

Professor Malin Parmar elected Vice President of the International Society for Stem Cell Research

Malin Parmar, Professor of Cellular Neuroscience at Lund University and Director of the Lund Stem Cell Center, has been elected Vice President of the International Society for Stem Cell Research, the world’s leading organisation for stem cell science and regenerative medicine. The International Society for Stem Cell Research (ISSCR) is an independent, global, nonprofit organization that brings tog

https://www.stemcellcenter.lu.se/article/professor-malin-parmar-elected-vice-president-international-society-stem-cell-research - 2026-09-11

Global study advances harmonised quality control for stem cell‑based therapies

A large international collaboration involving researchers from Lund University’s Lund Stem Cell Center has taken an important step toward making induced pluripotent stem cell (iPSC)–based therapies more globally accessible. Published in Stem Cell Reports, the study presents the first data‑driven international benchmarking of key quality control assays, showing how standardized methods can reduce v

https://www.stemcellcenter.lu.se/article/global-study-advances-harmonised-quality-control-stem-cell-based-therapies - 2026-09-11

What Does AI Really Cost Biomedical Research?

Artificial intelligence (AI) is becoming a routine tool in biomedical research, helping scientists analyse data, understand diseases and develop new treatments. But as AI models grow larger and more complex, they also rely on increasing amounts of energy, data storage and computing power. These environmental impacts are rarely visible to the researchers using the technology. As part of this year’s

https://www.stemcellcenter.lu.se/article/what-does-ai-really-cost-biomedical-research - 2026-09-11

New immunotherapy initiative aims to bring research closer to the clinic and opens new tenure‑track positions

A new joint initiative in immunotherapy between Lund University and Skåne University Hospital, Sweden, brings researchers, clinicians and engineers together to shorten the path from research to patient benefit. The initiative is accompanied by the recruitment of three new tenure‑track Assistant Professors in immunotherapy through the Lund University Programme for Global Excellence. The initiative

https://www.stemcellcenter.lu.se/article/new-immunotherapy-initiative-aims-bring-research-closer-clinic-and-opens-new-tenure-track-positions - 2026-09-11

Prestigious international award for Martin L. Olsson

Martin L. Olsson has received the International Society for Blood Transfusion (ISBT) Presidential Award, the highest international honour in transfusion medicine. The award is presented every two years to a researcher who has made outstanding contributions to transfusion medicine. Martin L. Olsson is recognised for translational research on red blood cells, following 35 years of work mapping the g

https://www.stemcellcenter.lu.se/article/prestigious-international-award-martin-l-olsson - 2026-09-11

81 million SEK drives new international effort to study aging and epigenetic changes in Parkinson’s Disease

Every person ages, yet only some develop Parkinson’s Disease, and scientists still don’t know why. A new international effort involving a research team from Lund University aims to uncover what makes certain aging brains more vulnerable than others, focusing on the epigenetic changes that accompany growing older. Their work is supported by a new 81 million SEK grant from the Aligning Science Acros

https://www.stemcellcenter.lu.se/article/81-million-sek-drives-new-international-effort-study-aging-and-epigenetic-changes-parkinsons-disease - 2026-09-11

Early-life B cells can drive leukemia later in life

Researchers at the Lund Stem Cell Center, Lund University, have discovered that a population of B cells formed shortly after birth store long-term immune memory and, in mice, can give rise to leukemia much later in life. Published in Cell Reports, the findings reveal how immune events at the very beginning of life can leave lasting biological imprints, linking early development to disease in old a

https://www.stemcellcenter.lu.se/article/early-life-b-cells-can-drive-leukemia-later-life - 2026-09-11

Lund Stem Cell Center joins BEYOND European postdoctoral programme in advanced therapies

The Lund Stem Cell Center at Lund University is a partner in BEYOND, a new European postdoctoral training programme designed to prepare the next generation of researchers in advanced cell and gene therapies. Coordinated by Fondazione Telethon, the programme is supported by €6 million from the Horizon Europe Marie Skłodowska Curie Actions (MSCA) COFUND scheme and will fund 35 international postdoct

https://www.stemcellcenter.lu.se/article/lund-stem-cell-center-joins-beyond-european-postdoctoral-programme-advanced-therapies - 2026-09-11

STEM-PD enters a new chapter as Cellular Intelligence acquires global rights to advance the stem cell therapy for Parkinson's Disease

The STEM PD clinical trial, a stem cell–based approach for Parkinson’s disease, is entering a new phase in its development. In May 2026, Cellular Intelligence, an AI native biotech company, announced that it has acquired global rights from the Danish pharmaceutical company, Novo Nordisk, to further advance the clinical development of the STEM PD programme. STEM‑PD is among a small number of plurip

https://www.stemcellcenter.lu.se/article/stem-pd-enters-new-chapter-cellular-intelligence-acquires-global-rights-advance-stem-cell-therapy - 2026-09-11

Hinduism as a Transnational Force

This article is over 5 years old, and the information may therefore be outdated. RESEARCHER OUTREACH: Catarina Kinnvall gave a presentation yesterday for The Tony Blair Foundation on the theme 'Hinduism as a Transnational Force' at a workshop in Pristina, Kososvo. The theme of the workshop was ’Religion and Conflict: Practical Policy Responses’ (An intensive training course for diplomats, public o

https://www.svet.lu.se/en/article/hinduism-transnational-force - 2026-09-11

Review of Disciplining the Transnational Mobility of People

This article is over 5 years old, and the information may therefore be outdated. Sara Kalm has written a review of the book Disciplining the Transnational Mobility of People, ed. Martin Geiger and Antoine Pécoud, published by Palgrave Macmillan. The review is published in the journal Nordic Journal of Migration Research, no. 4 2014. Learn more.  

https://www.svet.lu.se/en/article/review-disciplining-transnational-mobility-people - 2026-09-11